首页> 美国卫生研究院文献>other >In Vitro Dissolution Testing Strategies for Nanoparticulate Drug Delivery Systems: Recent Developments and Challenges
【2h】

In Vitro Dissolution Testing Strategies for Nanoparticulate Drug Delivery Systems: Recent Developments and Challenges

机译:纳米颗粒药物递送系统的体外溶解试验策略:最近的发展和挑战

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nanoparticulate systems have emerged as prevalent drug delivery systems over the past few decades. These delivery systems (such as liposomes, emulsions, nanocrystals, and polymeric nanocarriers) have been extensively used to improve bioavailability, prolong pharmacological effects, achieve targeted drug delivery, as well as reduce side effects. Considering that any unanticipated change in product performance of such systems may result in toxicity and/or change in vivo efficacy, it is essential to develop suitable in vitro dissolution/release testing methods to ensure product quality and performance, and to assist in product development. The present review provides an overview of the current in vitro dissolution/release testing methods such as dialysis, sample and separate, as well as continuous flow methods. Challenges and future directions in the development of standardized and biorelevant in vitro dissolution/release testing methods for novel nanoparticulate systems are discussed.
机译:在过去的几十年中,纳米颗粒系统已经成为普遍的药物输送系统。这些递送系统(例如脂质体,乳剂,纳米晶体和聚合物纳米载体)已被广泛用于提高生物利用度,延长药理作用,实现靶向药物递送以及减少副作用。考虑到此类系统产品性能的任何意外变化都可能导致毒性和/或体内功效的变化,因此必须开发合适的体外溶出/释放测试方法以确保产品质量和性能,并协助产品开发。本综述概述了当前的体外溶出/释放测试方法,例如透析,样品分离和分离以及连续流动方法。讨论了新型纳米微粒系统标准化和生物相关的体外溶出/释放测试方法开发中的挑战和未来方向。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号